Products & Services · Net Sales

Global Peripheral Interventions Pi Reporting Unit — Net Sales

Boston Scientific Global Peripheral Interventions Pi Reporting Unit — Net Sales increased by 0.6% to $702.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.6%, from $602.00M to $702.00M. Over 3 years (FY 2021 to FY 2024), Global Peripheral Interventions Pi Reporting Unit — Net Sales shows an upward trend with a 9.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ3 2025
Rolls up toTotal Revenue

How to read this metric

An increase indicates growing market share or higher clinical demand for the company's peripheral intervention product portfolio, while a decrease may signal increased competition or reduced procedure volumes in this specific medical specialty.

Detailed definition

This metric represents the total revenue generated from the sale of medical devices designed for peripheral vascular and...

Peer comparison

Comparable to peripheral vascular or interventional radiology segment revenues reported by diversified medical device manufacturers like Medtronic or Abbott Laboratories.

Metric ID: bsx_segment_peripheral_interventions_net_sales

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$473.00M$452.00M$462.00M$465.00M$478.00M$479.00M$477.00M$503.00M$535.00M$538.00M$534.00M$573.00M$590.00M$602.00M$645.00M$656.00M$698.00M$702.00M
QoQ Change-4.4%+2.2%+0.6%+2.8%+0.2%-0.4%+5.5%+6.4%+0.6%-0.7%+7.3%+3.0%+2.0%+7.1%+1.7%+6.4%+0.6%
YoY Change+1.1%+6.0%+3.2%+8.2%+11.9%+12.3%+11.9%+13.9%+10.3%+11.9%+20.8%+14.5%+18.3%+16.6%
Range$452.00M$702.00M
CAGR+9.7%
Avg YoY Growth+11.5%
Median YoY Growth+11.9%
Current Streak7 quarters growth

Frequently Asked Questions

What is Boston Scientific's global peripheral interventions pi reporting unit — net sales?
Boston Scientific (BSX) reported global peripheral interventions pi reporting unit — net sales of $702.00M in Q3 2025.
How has Boston Scientific's global peripheral interventions pi reporting unit — net sales changed year-over-year?
Boston Scientific's global peripheral interventions pi reporting unit — net sales increased by 16.6% year-over-year, from $602.00M to $702.00M.
What is the long-term trend for Boston Scientific's global peripheral interventions pi reporting unit — net sales?
Over 3 years (2021 to 2024), Boston Scientific's global peripheral interventions pi reporting unit — net sales has grown at a 9.8% compound annual growth rate (CAGR), from $1.82B to $2.41B.
What does global peripheral interventions pi reporting unit — net sales mean?
The total revenue earned from selling medical devices used in minimally invasive procedures outside of the heart and brain.